Fresh thinking, inspiration, and news from the Navihood

Aug 16, 2017

Dave Querry: What Agency of the Year means to me

Being recognized as Agency of the Year is a truly humbling experience—and a testament to the balance of creativity and sensitivity in the highly scientific and emotionally charged arena of oncology. At Navicor, we found this balance through a singular and focused passion—being the very best at communications and making a difference in oncology. With […]

Continue Reading
Jul 19, 2017

Becky Chanoux: What agency of the year means to me

Winning Agency of the Year is a testament to our commitment to executing our best work. It’s our hope that this award will help more people see what we’re capable of—and the value we can provide. To me, the honor means that I’m in the right place. I left academia and struggled to find my […]

Continue Reading
Jun 21, 2017

Tracy Terry-Allison: What agency of the year means to me

I see this honor as a win for oncology as a whole. As an oncology-focused agency, Navicor is living proof that high science can be smart, creative, and fun. It’s gratifying to win for the second time in the 4 years I’ve been here. Working in the highly regulated oncology industry is far more challenging […]

Continue Reading
Aug 15, 2016

The Power of Collective Wisdom

Every industry has a highly anticipated, multiday, crowd-drawing event. For creative-minded professionals, South by Southwest is a unique celebration of original music, independent films, and emerging technologies; for music lovers, events like Coachella and Firefly allow adoring fans to become one mass of dedicated groupies. For those whose mission in life is to defeat cancer, […]

Continue Reading
Jun 15, 2016

The Druggable Genome and Advancing Precision Medicine

It started with the human genome project1: Decloaking the human DNA and identifying the 3,000-odd genes making up the “druggable genome”—attractive targets for therapeutic intervention—has fueled the drive for precision medicine.2 Rare mutations, a wide range of cancer types, and a rapidly increasing number of targeted therapies in clinical development require genotype-matched clinical therapies. A […]

Continue Reading
Apr 28, 2016

Leave your mark!

job opening, hiring, Philadelphia

Philadelphia stands proud among our country’s greatest cities. Some of the landmarks we take for granted every day symbolize the marks left by amazing people before us. For example, when the Ben Franklin Bridge was completed, it was the largest suspension bridge ever built. City Hall, at the time of construction, was the tallest skyscraper […]

Continue Reading
Mar 14, 2016

The Evolution of “Going Mōˌbīl

The Evolution of “Going Mōbīl” In 1971, the British rock band, The Who, sang about the joys of going mobile (mōbīl)—being able to easily travel or detach based on the whims of spontaneity. Today, going mobile has a completely different connotation. As a society, we are infatuated with mobile technology. It is nearly impossible to […]

Continue Reading
Jan 28, 2016

The New Rules of Engagement: Enhancing Your Presence at Oncology Congresses

Engaging your audience is a perpetual challenge all marketers face, and healthcare marketing is no exception. We see it time and again—at every major healthcare congress, companies inevitably vie for traffic with increasingly bigger and louder approaches to customer engagement in the hopes that attendees will spend valuable time in their booths learning about their […]

Continue Reading
Dec 15, 2015

Observing Oncology Advertising Trends At ASH 2015

The 57th American Society of Hematology Annual Meeting and Exposition last week in Orlando was filled to the brim with the usual suspects—meeting rooms galore, rotating poster sessions and presentations, and an exhibit hall packed with the latest in pipeline trials and commercial brand information.   One of the biggest trends to emerge this year was the […]

Continue Reading
Dec 7, 2015

#BCSM helps oncology patients find quality scientific information and support through social media

At Navicor, we keep our finger on the pulse of oncology, be it through attending major conferences, following the latest drug approvals, or reading research articles. But we want to know more than just what’s going on in the pharmaceutical space; we want to know what’s going on with patients, too—what they’re interested in, where […]

Continue Reading